Pulse Biosciences (PLSE) Capital Expenditures (2015 - 2025)
Pulse Biosciences (PLSE) posted quarterly Capital Expenditures of $105000.0 for Q4 2025, up 238.71% year-over-year from $31000.0 in Q4 2024, and down 43.55% quarter-over-quarter from $186000.0 in Q3 2025.
Pulse Biosciences (PLSE) Capital Expenditures (2015 - 2025) Analysis & Trends
Pulse Biosciences' Capital Expenditures history runs 11 years deep, the most recent figure standing at $105000.0 for Q4 2025.
- In Q4 2025, Capital Expenditures rose 238.71% year-over-year to $105000.0; the TTM figure through Dec 2025 stood at $315000.0 (up 916.13% YoY), while the FY2025 annual figure was $315000.0, up 916.13% from the prior year.
- Capital Expenditures for Q4 2025 stood at $105000.0, down from $186000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $271000.0 in Q2 2022, with the low at -$276000.0 in Q4 2021.
- The 5-year median for Capital Expenditures is $39000.0 (2023), against an average of $47105.3.
- The sharpest annual moves came in 2024 and 2025: Capital Expenditures slumped 169.57% in 2024, then soared 1262.5% in 2025.
- Pulse Biosciences' Capital Expenditures stood at -$276000.0 in 2021, then soared by 114.86% to $41000.0 in 2022, then advanced by 4.88% to $43000.0 in 2023, then decreased by 27.91% to $31000.0 in 2024, then surged by 238.71% to $105000.0 in 2025.
- Business Quant data shows PLSE's Capital Expenditures at $105000.0 in Q4 2025, $186000.0 in Q3 2025, and -$2000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.33 Bn | 129.12 Bn | 1.96 Bn | 112.60 Mn |
| 2 | Becton Dickinson | 52.48 Bn | 51.62 Bn | 2.32 Bn | 143.00 Mn |
| 3 | Alcon | 35.71 Bn | 34.35 Bn | 1.68 Bn | 374.00 Mn |
| 4 | Resmed | 33.69 Bn | 32.22 Bn | 861.22 Mn | 51.13 Mn |
| 5 | Medline | 29.16 Bn | 26.48 Bn | 2.22 Bn | 111.00 Mn |
| 6 | West Pharmaceutical Services | 25.04 Bn | 24.61 Bn | 329.20 Mn | 43.20 Mn |
| 7 | Solventum | 15.41 Bn | 15.01 Bn | 1.29 Bn | 83.00 Mn |
| 8 | Cooper Companies | 14.79 Bn | 14.65 Bn | 735.40 Mn | 86.40 Mn |
| 9 | Baxter International | 13.59 Bn | 11.44 Bn | 1.03 Bn | 116.00 Mn |
| 10 | Pulse Biosciences | 3.44 Bn | 3.44 Bn | 161,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 105,000.00 |
| Dec 31, 2025 | 105,000.00 |
| Sep 30, 2025 | 186,000.00 |
| Sep 30, 2025 | 186,000.00 |
| Jun 30, 2025 | -2,000.00 |
| Jun 30, 2025 | -2,000.00 |
| Mar 31, 2025 | 26,000.00 |
| Mar 31, 2025 | 26,000.00 |
| Dec 31, 2024 | 31,000.00 |
| Dec 31, 2024 | 31,000.00 |
| Sep 30, 2024 | -16,000.00 |
| Sep 30, 2024 | -16,000.00 |
| Jun 30, 2024 | 16,000.00 |
| Jun 30, 2024 | 16,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Sep 30, 2023 | 23,000.00 |
| Sep 30, 2023 | 23,000.00 |
| Jun 30, 2023 | 16,000.00 |
| Jun 30, 2023 | 16,000.00 |